Understanding Cancer-Specific Mechanosensing Mechanisms and Their Application to Drug Discovery

Cancer is a disease characterized by its remarkable stiffness. Dr. Ishihara, the principal investigator of the project, recently became the first in the world to identify the transcription factor ATF5 as a molecule that is highly expressed in cancer cells and responds to mechanical stiffness. He also discovered that signaling through ATF5 contributes to cancer progression.

Building on these findings, this research focuses on pancreatic cancer—a particularly hard and treatment-resistant type of cancer—to investigate in detail how ATF5 responds to stiffness and drives disease progression. The project also aims to develop novel cancer therapeutics that target ATF5.

Project Members

Principal Investigator

Seiichiro Ishihara

Assistant Professor
Faculty of Advanced Life Science
Hokkaido University

Co-Investigator

Manabu Igarashi

Associate Professor
International Institute for Zoonosis Control
Hokkaido University

Co-Investigator

Masahiro Sonoshita

Professor
Institute for Genetic Medicine
Hokkaido University

Division of Biomedical Oncology

Co-Investigator

Toyoyuki Ose

Professor
Faculty of Advanced Life Science
Hokkaido University

Laboratory of Structural & Biological Chemistry